1. Home
  2. CPIX vs LSTA Comparison

CPIX vs LSTA Comparison

Compare CPIX & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • LSTA
  • Stock Information
  • Founded
  • CPIX 1999
  • LSTA 1980
  • Country
  • CPIX United States
  • LSTA United States
  • Employees
  • CPIX N/A
  • LSTA N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • CPIX Health Care
  • LSTA Health Care
  • Exchange
  • CPIX Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • CPIX 35.4M
  • LSTA 31.2M
  • IPO Year
  • CPIX 2009
  • LSTA N/A
  • Fundamental
  • Price
  • CPIX $4.52
  • LSTA $2.67
  • Analyst Decision
  • CPIX
  • LSTA Strong Buy
  • Analyst Count
  • CPIX 0
  • LSTA 1
  • Target Price
  • CPIX N/A
  • LSTA $15.00
  • AVG Volume (30 Days)
  • CPIX 4.5M
  • LSTA 63.6K
  • Earning Date
  • CPIX 03-04-2025
  • LSTA 02-27-2025
  • Dividend Yield
  • CPIX N/A
  • LSTA N/A
  • EPS Growth
  • CPIX N/A
  • LSTA N/A
  • EPS
  • CPIX N/A
  • LSTA N/A
  • Revenue
  • CPIX $36,785,442.00
  • LSTA N/A
  • Revenue This Year
  • CPIX N/A
  • LSTA N/A
  • Revenue Next Year
  • CPIX N/A
  • LSTA N/A
  • P/E Ratio
  • CPIX N/A
  • LSTA N/A
  • Revenue Growth
  • CPIX N/A
  • LSTA N/A
  • 52 Week Low
  • CPIX $1.04
  • LSTA $2.19
  • 52 Week High
  • CPIX $6.43
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 68.47
  • LSTA 42.17
  • Support Level
  • CPIX $2.08
  • LSTA $2.45
  • Resistance Level
  • CPIX $6.43
  • LSTA $2.74
  • Average True Range (ATR)
  • CPIX 0.59
  • LSTA 0.32
  • MACD
  • CPIX 0.24
  • LSTA -0.05
  • Stochastic Oscillator
  • CPIX 56.09
  • LSTA 16.48

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: